Jeff Yass’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RLMD
JHC
Jeff Yass's RLMD Position: Q3 2026 in Review
Jeff Yass increased its Relmada Therapeutics (RLMD) stake by 9.9% in Q3 2026, buying an estimated $14.6K and bringing the position to 33,085 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #12389.
Jeff Yass first reported a position in RLMD in Q4 2019 and has held it in 22 quarters since. The position peaked at $7.04M in Q1 2026. 117 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.
- Jeff Yass held 33,085 shares of Relmada Therapeutics worth $125K as of Q3 2026.
- Jeff Yass bought 2,977 Relmada Therapeutics shares in Q3 2026, an estimated $14.6K.
- Relmada Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12389 holding.
- Jeff Yass first reported a position in Relmada Therapeutics in Q4 2019 and has held it in 22 quarters since.
- Jeff Yass's Relmada Therapeutics position peaked at $7.04M in Q1 2026.
- 117 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.